We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
System for transcribing legislation into 24 languages overwhelmed by deluge of initiatives
Pharmaceutical group says parts of law are unconstitutional
Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected
Drugmaker seeks opportunities due to ageing population and burgeoning biotech industry
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Move for veterinary pharma company would represent one of biggest UK private equity deals this year
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?
Appeals court says some liability releases are ‘appropriate’ under US bankruptcy law
World’s biggest gene sequencing company rejects EU’s fast- track application
Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes
UK unveils reforms worth £650mn to boost the life sciences sector
Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
As McDonald’s is targeted, governments also need to tighten and enforce rules
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
Governments and some pharma companies try to tackle problem linked with drug resistance
Gene sequencing company heads for pivotal vote in battle with activist investor Carl Icahn
Human life appears to have an upper limit that has yet to be extended
Manufacturers racing to build what could be one of industry’s biggest markets must tread with care
Development chief raises worry over innovation after FTC sues to block Amgen-Horizon deal
The US trust buster’s opposition to the tie-up focuses on so-called pharmacy benefit managers
UK Edition
